Literature DB >> 24732775

Employment status in persons with and without HIV infection in Denmark: 1996-2011.

Rebecca Legarth1, Lars Haukali Omland, Gitte Kronborg, Carsten S Larsen, Court Pedersen, Gitte Pedersen, Ulrik Bak Dragsted, Jan Gerstoft, Niels Obel.   

Abstract

OBJECTIVE: To estimate annual employment rates and disability retirement rates (DRRs) among HIV-infected individuals and population controls during the period 1996-2011.
DESIGN: A population-based cohort study including all HIV-infected individuals born in Denmark and not reporting intravenous (i.v.) drug abuse as a route of HIV infection or diagnosed with hepatitis C infection (n = 2799) and 22,369 individually matched persons from the background population. Study inclusion was 1 January 1996 or HIV diagnosis, which ever came last.
METHODS: Data on employment status and disability pension were extracted from Danish national registries. Employment rate and DRR were estimated in each calendar year after study inclusion for the cohorts included before 1996 (pre-1996), 1996-1999 and 2000-2011.
RESULTS: Employment rate in the year of study inclusion increased from 54.8% [95% confidence interval (CI) 50.5-59.6] in the pre-1996 cohort to 74.6% (66.9-83.2) and 77.4% (72.8-82.2) in the 1996-1999 and 2000-2011 cohorts, respectively, compared with 85.9-87.2% in the comparison cohorts. Five years from study inclusion, employment rates were 56.1 (51.4-61.1), 66.2 (58.7-74.6) and 70.9% (65.0-77.3) in the pre-1996, 1996-1999 and 2000-2011 cohorts, respectively, compared with 82.5-85.6% in the comparison cohorts. Five years from study inclusion, DRRs were 32.3 (28.9-36.3) in the pre-1996 cohort and decreased to 17.8 (14.1-22.4) and 11.6% (9.4-14.4) in the 1996-1999 and 2000-2011 cohorts, respectively, compared with 5.1-7.2% in the comparison cohorts.
CONCLUSION: After the introduction of HAART, employment rates have increased profoundly among HIV-infected individuals, but have remained lower than in the background population. During the same period, DRRs decreased among HIV-infected individuals, but still remained higher than in the background population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24732775     DOI: 10.1097/QAD.0000000000000257

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

Review 1.  Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis.

Authors:  Vitor H F Oliveira; Ana L Borsari; Allison R Webel; Kristine M Erlandson; Rafael Deminice
Journal:  Eur J Clin Nutr       Date:  2020-04-27       Impact factor: 4.016

2.  Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.

Authors:  Bohdan Nosyk; Jeong E Min; Viviane D Lima; Robert S Hogg; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-07-16       Impact factor: 12.767

3.  Smoking and renal function in people living with human immunodeficiency virus: a Danish nationwide cohort study.

Authors:  Magnus Glindvad Ahlström; Bo Feldt-Rasmussen; Rebecca Legarth; Gitte Kronborg; Court Pedersen; Carsten Schade Larsen; Jan Gerstoft; Niels Obel
Journal:  Clin Epidemiol       Date:  2015-08-28       Impact factor: 4.790

4.  Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.

Authors:  César Garriga; Patricia García de Olalla; Josep M Miró; Inma Ocaña; Hernando Knobel; Maria Jesús Barberá; Victoria Humet; Pere Domingo; Josep M Gatell; Esteve Ribera; Mercè Gurguí; Andrés Marco; Joan A Caylà
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

5.  Increase in Unemployment over the 2000's: Comparison between People Living with HIV and the French General Population.

Authors:  Margot Annequin; France Lert; Bruno Spire; Rosemary Dray-Spira
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

6.  Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study.

Authors:  Luigia Elzi; Anna Conen; Annalea Patzen; Jan Fehr; Matthias Cavassini; Alexandra Calmy; Patrick Schmid; Enos Bernasconi; Hansjakob Furrer; Manuel Battegay
Journal:  Open Forum Infect Dis       Date:  2016-02-01       Impact factor: 3.835

7.  The relationship between socio-demographic factors, health status, treatment type, and employment outcome in patients with inflammatory bowel disease in Japan.

Authors:  J Mahlich; K Matsuoka; Y Nakamura; R Sruamsiri
Journal:  BMC Public Health       Date:  2017-07-04       Impact factor: 3.295

8.  Late Presentation of HIV Infection in the Netherlands: Reasons for Late Diagnoses and Impact on Vocational Functioning.

Authors:  S E M van Opstal; J S van der Zwan; M N Wagener; S K Been; H S Miedema; P D D M Roelofs; E C M van Gorp
Journal:  AIDS Behav       Date:  2018-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.